Annapolis Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-208
| Closed | -$15.9K | – | 396 |
|
|
2023
Q4 | $15.9K | Hold |
208
| – | – | ﹤0.01% | 304 |
|
|
2023
Q3 | $14.4K | Hold |
208
| – | – | ﹤0.01% | 302 |
|
|
2023
Q2 | $19.6K | Hold |
208
| – | – | 0.01% | 272 |
|
|
2023
Q1 | $17.2K | Hold |
208
| – | – | 0.01% | 260 |
|
|
2022
Q4 | $15.5K | Hold |
208
| – | – | 0.01% | 263 |
|
|
2022
Q3 | $17K | Hold |
208
| – | – | 0.01% | 273 |
|
|
2022
Q2 | $20K | Hold |
208
| – | – | 0.01% | 245 |
|
|
2022
Q1 | $24K | Buy |
208
+115
| +124% | +$13.3K | 0.01% | 243 |
|
|
2021
Q4 | $12K | Hold |
93
| – | – | ﹤0.01% | 299 |
|
|
2021
Q3 | $11K | Hold |
93
| – | – | ﹤0.01% | 284 |
|
|
2021
Q2 | $10K | Hold |
93
| – | – | ﹤0.01% | 266 |
|
|
2021
Q1 | $8K | Hold |
93
| – | – | ﹤0.01% | 271 |
|
|
2020
Q4 | $8K | Buy |
+93
| New | +$8K | ﹤0.01% | 267 |
|